Israel’s Innovation Authority is allocating NIS 113 million for a new research and development center for startups to build biodevices based on biochips. This area is known as bio-convergence and is expected to be a growth engine and source of diversification for Israeli industry.
NIS 113 million for biodevices R&D
This entry was posted in Economy & Business. Bookmark the permalink.